Pluri Subsidiary Coffeesai Partners with Mexico’s INCAFECH to Advance Cell-Based Coffee Manufacturing

Core Insights - Pluri Inc. is recognized as a promising long-term penny stock with significant upside potential, particularly following its recent collaboration with a Mexican public body to advance cell-based coffee manufacturing [1][3]. Group 1: Collaboration and Innovation - Pluri's subsidiary, Coffeesai Ltd., has entered into a collaboration agreement with Instituto del Café de Chiapas/INCAFECH to promote cell-based coffee production in Chiapas, Mexico, which is known as the leading coffee-growing region in the country [1][2]. - The partnership aims to establish Chiapas as a hub for innovation in coffee manufacturing, leveraging state support to enhance the commercialization of cell-based coffee products [1][2]. Group 2: Business Model and Revenue Generation - Coffeesai utilizes Pluri's proprietary 3D cell expansion platform and two decades of expertise to develop sustainable cell-based coffee products, outlining a multi-phase, capital-light roadmap to mitigate commercialization risks [2][3]. - The collaboration is expected to create shareholder value through potential non-dilutive revenues from licensing and technology transfer, as well as recurring revenue streams from royalty-bearing models and joint ventures [3]. Group 3: Company Overview - Pluri Inc. is a biotechnology company focused on researching, developing, and manufacturing cell-based products and related technologies across various industries [4].